March 2020

Case Report: Precision Oncology Tumor Board 
Exploiting homologous recombination repair alterations in metastatic castrate-resistant prostate cancer: a case report and literature review
Stephen Zachary Peeke, Robert Lopez, Benjamin Gartrell
Precision Cancer Medicine  
2020;
3:
10  
Case Report: Precision Oncology Tumor Board 
Utilizing genomic profiling in a patient with a thoracic malignancy of uncertain primary: case report
Jose N. Galeas, Nishi Shah, Shabnam Ridvi, Jennifer Chuy
Precision Cancer Medicine  
2020;
3:
9  
Case Report: Precision Oncology Tumor Board 
Targeting EGFR mutations needs to be more precise with co-mutations
Paul R. Walker, Nitika Sharma, Praveen Namireddy
Precision Cancer Medicine  
2020;
3:
8  
Review Article 
Non-small cell lung cancer PDL1 >50%—should we go single or combo?
Waleed Kian, Laila C. Roisman, Dina Levitas, Nadav Wallach, Adam Abo-Sharb, Aharon Y. Cohen, Alexander Yakobson, Nir Peled, Yulia Dudnik
Precision Cancer Medicine  
2020;
3:
7  
Review Article 
Annotating the next generation sequencing report
Miguel A. Molina-Vila, Clara Mayo-de-las-Casas, Mónica Garzón-Ibáñez, Núria Jordana-Ariza, Beatriz García-Peláez, Ariadna Balada-Bel, Rafael Rosell
Precision Cancer Medicine  
2020;
3:
6  
Review Article 
Non-small cell lung cancer targetable mutations: present and future
Peter Vu, Sandip Pravin Patel
Precision Cancer Medicine  
2020;
3:
5  
Review Article 
Circulating tumor cells: moving forward into clinical applications
Zahra Eslami-S, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières
Precision Cancer Medicine  
2020;
3:
4  
Original Article 
Significance of alectinib in anaplastic lymphoma kinase-tyrosine kinase inhibitors for anaplastic lymphoma kinase-positive patients with non–small cell lung cancer
Yasuhiro Chikaishi, Kenichi Kobayashi, Hiroki Matsumiya, Akihiro Taira, Yusuke Nabe, Shinji Shinohara, Taiji Kuwata, Masaru Takenaka, Soichi Oka, Ayako Hirai, Kouji Kuroda, Naoko Imanishi, Yoshinobu Ichiki, Fumihiro Tanaka
Precision Cancer Medicine  
2020;
3:
3  
Editorial 
Sharing data: a requirement for expanding precision oncology
Olivier Trédan
Precision Cancer Medicine  
2020;
3:
2  
Editorial 
The current and future revolution in lung cancer screening and management
Waleed Kian, Nadav Wallach, Nir Peled
Precision Cancer Medicine  
2020;
3:
1